Symposium 9 Progress in Tumor Immunotherapy

[SY9-4] Developing personalized cancer vaccines

Catherine J. Wu^1,2 (1.Dana-Farber Cancer Institute & Harvard Medical School, Medical Oncology, Department of Medicine, United States of America, 2.Department of Medicine, Harvard Medical School, United States of America)

Catherine J. Wu, MD is a Professor of Medicine and Chief, Division of Stem Cell Transplantation and Cellular Therapies at the Dana-Farber Cancer Institute, Boston. She received her M.D. from Stanford University School of Medicine and completed her clinical training in Internal Medicine and Hematology-Oncology at the Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston, MA. She joined the staff at the Dana-Farber Cancer Institute in 2000. At DFCI, she has initiated an integrated program of research and clinical activities that focuses on dissecting the basis of effective anti-tumor immunity. Her laboratory has focused on the use of genomics-based approaches to discover immunogenic antigen targets and to understand the molecular basis of therapeutic response and resistance. She has led early phase clinical trials to test personalized tumor vaccines, including following hematopoietic stem cell transplantation.